Emerging hallmarks of metabolic reprogramming in prostate cancer

F Lasorsa, NA di Meo, M Rutigliano, M Ferro… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) is the most common male malignancy and the fifth leading cause of
cancer death in men worldwide. Prostate cancer cells are characterized by a hybrid …

[HTML][HTML] Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets

R Liu, JH Lee, J Li, R Yu, L Tan, Y Xia, Y Zheng… - Molecular cell, 2021 - cell.com
Lipid droplets are important for cancer cell growth and survival. However, the mechanism
underlying the initiation of lipid droplet lipolysis is not well understood. We demonstrate here …

The emerging roles of PHOSPHO1 and its regulated phospholipid homeostasis in metabolic disorders

Y Liu, Y Wu, M Jiang - Frontiers in Physiology, 2022 - frontiersin.org
Emerging evidence suggests that phosphoethanolamine/phosphocholine phosphatase 1
(PHOSPHO1), a specific phosphoethanolamine and phosphocholine phosphatase, is …

The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation

Q Ma, H Jiang, L Ma, G Zhao, Q Xu… - Proceedings of the …, 2023 - National Acad Sciences
Aberrantly upregulated choline phospholipid metabolism is a novel emerging hallmark of
cancer, and choline kinase α (CHKα), a key enzyme for phosphatidylcholine production, is …

Molecular mechanism of the role of Mare Nectaris in the Feng-Flavor Baijiu aging

W Jia, A Du, Z Fan, R Zhang, Y Li, Q Shi, L Shi, X Chu - Lwt, 2021 - Elsevier
A special storage container called Mare Nectaris bears a close relationship with Feng-flavor
Baijiu quality during aging. The goal of this work is to unveil molecular mechanism of the …

Recent advances in the design of choline kinase α inhibitors and the molecular basis of their inhibition

B Rubio‐Ruiz, L Serrán‐Aguilera… - Medicinal research …, 2021 - Wiley Online Library
Upregulated choline metabolism, characterized by an increase in phosphocholine (PCho),
is a hallmark of oncogenesis and tumor progression. Choline kinase (ChoK), the enzyme …

Choline kinase: an unexpected journey for a precision medicine strategy in human diseases

JC Lacal, T Zimmerman, JM Campos - Pharmaceutics, 2021 - mdpi.com
Choline kinase (ChoK) is a cytosolic enzyme that catalyzes the phosphorylation of choline to
form phosphorylcholine (P Cho) in the presence of ATP and magnesium. ChoK is required …

Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth

G Velazquez-Torres, E Fuentes-Mattei… - Gastroenterology …, 2020 - academic.oup.com
Background Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with
pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but …

ChoK-full of potential: Choline kinase in B cell and T cell malignancies

S Gokhale, P Xie - Pharmaceutics, 2021 - mdpi.com
Aberrant choline metabolism, characterized by an increase in total choline-containing
compounds, phosphocholine and phosphatidylcholine (PC), is a metabolic hallmark of …

DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism

Z Li, Y Tan, X Li, J Quan, AM Bode, Y Cao… - Cell Death & Disease, 2022 - nature.com
The short-chain dehydrogenase/reductase (SDR) superfamily has essential roles in lipid
metabolism and redox sensing. In recent years, accumulating evidence highlights the …